Evidence map›Paper›PMID 27117471›Full record

ArticleClinical chemistry2016

A Novel Peptidomic Approach to Strain Typing of Clinical Acinetobacter baumannii Isolates Using Mass Spectrometry.

Honghui Wang, Steven K Drake, Chen Yong, Marjan Gucek, Margaret Tropea, Avi Z Rosenberg, John P Dekker, Anthony F Suffredini

Registry-linked trialAbstract read
In one paragraph

Article in Clinical chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00077909 (Biomarkers and Protein Mass Expression Profiles in Bronchoalveolar Lavage From Patients With Lung Infiltrates), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00077909 recruitingnot on this map

Biomarkers and Protein Mass Expression Profiles in Bronchoalveolar Lavage From Patients With Lung Infiltrates

TypeobservationalSponsorNational Institutes of Health Clinical Center (CC)Ran2004Enrolled750ConditionsPneumonia, Pulmonary Disease, Lung Disease
3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Rapid and Culture Free Identification ofFrontiers in microbiology · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Deciphering Multifactorial Resistance Phenotypes inMolecular & cellular proteomics : MCP · 2018
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Honghui WangCritical Care Medicine Department, Clinical Center.
Steven K DrakeCritical Care Medicine Department, Clinical Center.
Chen YongProteomic Core Facility, National Heart Lung and Blood Institute.
Marjan GucekProteomic Core Facility, National Heart Lung and Blood Institute.
Margaret TropeaCritical Care Medicine Department, Clinical Center.
Avi Z RosenbergKidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases.
John P DekkerMicrobiology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
Anthony F SuffrediniCritical Care Medicine Department, Clinical Center, asuffredini@cc.nih.gov.

Funding

Proteomics CoreZICHL005903 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI GUCEK, MARJAN · 2009 to 2022
$23.3M
Diagnostic and Prognostic Biomarkers in PneumoniaZIACL008063 · CLC · CLINICAL CENTER · PI SUFFREDINI, ANTHONY F. · 2009 to 2025
$0k
Novel Applications of Mass Spectrometry and Proteomics to Infectious Disease DiagnosticsZIACL080019 · CLC · CLINICAL CENTER · PI DEKKER, JOHN · 2014 to 2018
$0k
Intramural NIH HHS ZIA CL008063
6 · The paper itself

Abstract

backgroundAcinetobacter baumannii is a common nosocomial pathogen and strain-typing methods play an important role in hospital outbreak investigations and epidemiologic surveillance. We describe a method for identifying strain-specific peptide markers based on LC-MS/MS profiling of digested peptides. This method classified a test set of A. baumannii isolates collected from a hospital outbreak with discriminatory performance exceeding that of MALDI-TOF mass spectrometry.

methodsFollowing the construction of a species "pan-peptidome" by in silico translation and digestion of whole genome sequences, a hypothetical set of genome-specific peptides for an isolate was constructed from the disjoint set of the pan-peptidome and the isolate's calculated peptidome. The genome-specific peptidome guided selection of highly expressed genome-specific peptides from LC-MS/MS experimental profiles as potential peptide markers. The species specificity of each experimentally identified genome-specific peptide was confirmed through a Unipept lowest common ancestor analysis.

resultsFifteen A. baumannii isolates were analyzed to derive a set of genome- and species-specific peptides that could be used as peptide markers. Identified peptides were cross-checked with protein BLAST against a set of 22 A. baumannii whole genome sequences. A subset of these peptide markers was confirmed to be present in the actual peptide profiles generated by multiple reaction monitoring and targeted LC-MS/MS. The experimentally identified peptides separated these isolates into 6 strains that agreed with multilocus sequence typing analysis performed on the same isolates.

conclusionsThis approach may be generalizable to other bacterial species, and the peptides may be useful for rapid MS strain tracking of isolates with broad application to infectious disease diagnosis.

Indexed as

ProteomicsTandem Mass SpectrometryAcinetobacter baumanniiBacterial Typing TechniquesChromatography, LiquidHumansPeptidesPeptides

Identifiers

PMID27117471
PMCPMC5548180

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.